A phase I/II evaluation of stavudine (d4T) in children with HIV infection

International Antiviral News

Volumn 4, Issue 6, 1996, Pages 109-111

  Federici, M E ^a   Kline, M W ^a   Rutkiewicz, V L ^a   Church, J A ^a   Harris, A T ^a   Evans, K ^a   Kaul, S ^a   Wheeler, S ^a   Smaldone, L ^a   Dunkle, L M ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DIDANOSINE; STAVUDINE; ZIDOVUDINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MULTICENTER STUDY; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 0029844502     PISSN: 09652310     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)